Yahoo Web Search

Search results

1. Xilio Therapeutics, Inc.

   NasdaqGS: XLO

   1.0200

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   0.0000 (0.00%)

   At close:4:00 PM EDTThu. Jun 6, 2024

   1.0200 0.00 (0.00%)

   After hrs:6:15 PM EDTThu. Jun 6, 2024

   Nasdaq Real Time Price (USD) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	1.0100
     High	1.0699
     Low	1.0000

   • Mkt Cap	37.65M
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	1.0200
     52 Wk. Low	0.4900
     52 Wk. High	3.2500

   More about XLO

   Related stocks

   • CADL
     Candel Therapeutics, Inc.
     CADL
     7.12
     -11.33%
   • TYRA
     Tyra Biosciences, Inc.
     TYRA
     19.80
     +4.05%
   • HOWL
     Werewolf Therapeutics, Inc.
     HOWL
     3.5000
     -2.51%
   • IMRX
     Immuneering Corporation
     IMRX
     1.4100
     +2.17%
   • TNYA
     Tenaya Therapeutics, Inc.
     TNYA
     3.6700
     -0.27%

   More on Yahoo Finance

2. stockanalysis.com › stocks › xloXilio Therapeutics, Inc. (XLO) Stock Price, Quote & News ...

   stockanalysis.com › stocks › xlo

   • Cached

   6 days ago · Get a real-time Xilio Therapeutics, Inc. (XLO) stock price quote with breaking news, financials, statistics, charts and more.

3. markets.businessinsider.com › stocks › xlo-stockXilio Therapeutics Stock Price | XLO Stock Quote, News, and ...

   markets.businessinsider.com › stocks › xlo-stock

   • Cached

   6 days ago · The latest Xilio Therapeutics stock prices, stock quotes, news, and XLO history to help you invest and trade smarter.

4. www.bloomberg.com › quote › XLO:USXLO: Xilio Therapeutics Inc Stock Price Quote - NASDAQ GS ...

   www.bloomberg.com › quote › XLO:US

   • Cached

   2 days ago · Stock analysis for Xilio Therapeutics Inc (XLO:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

   • Employees: 89

5. www.marketbeat.com › stocks › NASDAQXilio Therapeutics (XLO) Stock Price, News & Analysis

   www.marketbeat.com › stocks › NASDAQ

   • Cached

   1 day ago · Should You Buy or Sell Xilio Therapeutics Stock? Get The Latest XLO Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.

   • 0.3/5
   • Email: monique@thrustsc.com

   • Phone: (857) 524-2466
   • Employees: 73

6. www.morningstar.com › stocks › xnasXLO Stock Price Quote | Morningstar

   www.morningstar.com › stocks › xnas

   • Cached

   May 30, 2024 · See the latest Xilio Therapeutics Inc stock price (XLO:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

7. markets.businessinsider.com › news › stocksXilio Therapeutics Announces Pipeline and Business Updates ...

   markets.businessinsider.com › news › stocks

   • Cached

   May 14, 2024 · XTX301 is an investigational tumor-activated, engineered IL-12 molecule designed to potently stimulate anti-tumor immunity and reprogram the TME of poorly immunogenic “cold” tumors towards an...

8. People also ask

   What does xilio Therapeutics Inc (XLO) do?

   • The Company focuses on developing tumor-targeted immuno-oncology therapeutics. Xilio Therapeutics serves medical sector in the United States. Stock analysis for Xilio Therapeutics Inc (XLO:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

   XLO: Xilio Therapeutics Inc Stock Price Quote - NASDAQ GS - Bloomberg

   www.bloomberg.com/quote/XLO:US

   See all results for this question

   Where can I buy XLO stock?

   • Shares of XLO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here.

   Xilio Therapeutics (XLO) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com/stocks/NASDAQ/XLO/

   See all results for this question

   When did xilio Therapeutics IPO?

   • Xilio Therapeutics (XLO) raised $125 million in an IPO on Friday, October 22nd 2021. The company issued 7,353,000 shares at a price of $16.00-$18.00 per share. Who are Xilio Therapeutics' major shareholders?

   Xilio Therapeutics (XLO) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com/stocks/NASDAQ/XLO/

   See all results for this question

   Is xilio a cytokine company?

   • The company also develops cytokine programs, which comprises XTX202, a tumor-activated IL-2; and XTX301, an investigational tumor-activated, engineered IL-12 molecule. Xilio Therapeutics, Inc. was founded in 2016 and is headquartered in Waltham, Massachusetts.

   Xilio Therapeutics (XLO) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com/stocks/NASDAQ/XLO/

   See all results for this question

9. www.marketscreener.com › quote › stockXilio Therapeutics, Inc. Stock (XLO) - Quote Nasdaq ...

   www.marketscreener.com › quote › stock

   • Cached

   May 29, 2024 · Press releases Xilio Therapeutics, Inc. Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results.